ClearView 3 Multifocal IOL
The ClearView 3 MIOL is now FDA approved!
The Lenstec ClearView 3 Multifocal IOL is a presbyopic lens that is intended to provide superior HD vision. It is a asymmetric segmented multifocal IOL (MIOL) that is designed to improve contrast sensitivity, minimize halos and glare, and provide superior near, intermediate and distance vision compared to other presbyopic IOLs.
The Lenstec ClearView 3 MIOL provides both surgeon and patient a very high level of confidence based on the manufacturing tolerances and the availability of 0.25 Diopter power increments. This process enables Lenstec to manufacture the ClearView 3 to an industry leading ±0.11 Diopters of the intended power, allowing it to be distinguished as part of the Precision Series. The ClearView 3 comes with a true 3.0 diopter sector-shaped add with a seamless transition zone between the distance and near segments.
Several prospective studies have been performed on the ClearView 3 with results identifying a high level of near, intermediate and distance vision, very limited amounts of visual side effects and extremely high patient satisfaction and spectacle independence ratings.
The Lenstec ClearView 3 Multifocal IOL is a presbyopic lens that is intended to provide superior HD vision. It is a asymmetric segmented multifocal IOL (MIOL) that is designed to improve contrast sensitivity, minimize halos and glare, and provide superior near, intermediate and distance vision compared to other presbyopic IOLs.
The Lenstec ClearView 3 MIOL provides both surgeon and patient a very high level of confidence based on the manufacturing tolerances and the availability of 0.25 Diopter power increments. This process enables Lenstec to manufacture the ClearView 3 to an industry leading ±0.11 Diopters of the intended power, allowing it to be distinguished as part of the Precision Series. The ClearView 3 comes with a true 3.0 diopter sector-shaped add with a seamless transition zone between the distance and near segments.
Several prospective studies have been performed on the ClearView 3 with results identifying a high level of near, intermediate and distance vision, very limited amounts of visual side effects and extremely high patient satisfaction and spectacle independence ratings.